Literature DB >> 33346872

[Interdisciplinary S2k guidelines on the diagnosis and treatment of vaginal carcinoma and its precursors-recommendations on surgical pathology for histopathological workup, diagnostics, and reporting].

Lars-Christian Horn1, Anne Kathrin Höhn2, Monika Hampl3, Grit Mehlhorn4, Markus Follmann5, Hans-Georg Schnürch6.   

Abstract

Primary vaginal carcinoma is rare. There are two pathogenetic pathways, one associated with HPV high-risk infection and another one with inactivation of p53. Vaginal Paget's disease is rare and mostly associated with vulvar disease or represents intravaginal spread of associated locoregional cancer. Diagnostic vaginal biopsies should be examined by step sections on H&E. Sentinel lymph nodes should be processed completely using ultrastaging. Morphology-based prognostic factors with good clinical evidence are tumour stage and lymph node status. Molecular markers are not currently relevant for treatment decision and prognosis.

Entities:  

Keywords:  Cancer; Diagnostic; Guidelines; Histopathology; Prognosis; Staging; Treatment; VaIN; Vagina; WHO; Workup

Year:  2021        PMID: 33346872     DOI: 10.1007/s00292-020-00876-8

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  70 in total

1.  Carcinoma of the vagina.

Authors:  U Beller; M Sideri; P Maisonneuve; J L Benedet; A P Heintz; H Y Ngan; S Pecorelli; F Odicino; W T Creasman
Journal:  J Epidemiol Biostat       Date:  2001

2.  Sentinel lymph node procedure in early vulvar cancer.

Authors:  Nurettin Boran; Fulya Kayikcioglu; Metin Kir
Journal:  Gynecol Oncol       Date:  2003-08       Impact factor: 5.482

3.  Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples.

Authors:  L Alemany; M Saunier; L Tinoco; B Quirós; I Alvarado-Cabrero; M Alejo; E A Joura; P Maldonado; J Klaustermeier; J Salmerón; C Bergeron; K U Petry; N Guimerà; O Clavero; R Murillo; C Clavel; V Wain; D T Geraets; R Jach; P Cross; C Carrilho; C Molina; H R Shin; V Mandys; A M Nowakowski; A Vidal; L Lombardi; H Kitchener; A R Sica; C Magaña-León; M Pawlita; W Quint; I G Bravo; N Muñoz; S de Sanjosé; F X Bosch
Journal:  Eur J Cancer       Date:  2014-08-21       Impact factor: 9.162

Review 4.  Small cell carcinoma of the gynecologic tract: a multifaceted spectrum of lesions.

Authors:  Maria Atienza-Amores; Elena Guerini-Rocco; Robert A Soslow; Kay J Park; Britta Weigelt
Journal:  Gynecol Oncol       Date:  2014-05-27       Impact factor: 5.482

5.  Concomitant radiotherapy and hyperthermia for primary carcinoma of the vagina: a cohort study.

Authors:  Mustafa Aktas; Diederick de Jong; Joost J Nuyttens; Jacoba van der Zee; Dennis H M Wielheesen; Erdogan Batman; Curt W Burger; Anca C Ansink
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2006-06-13       Impact factor: 2.435

6.  Extravesical Pagetoid Spread of Urothelial Carcinoma in Situ. A Report of Five Cases.

Authors:  Mahmut Akgul; Phillip B Bomeisl; Gregory T MacLennan
Journal:  Anal Quant Cytopathol Histpathol       Date:  2015-12

7.  Natural history of vaginal intraepithelial neoplasia.

Authors:  M Aho; E Vesterinen; B Meyer; E Purola; J Paavonen
Journal:  Cancer       Date:  1991-07-01       Impact factor: 6.860

8.  Human papillomavirus as a favorable prognostic biomarker in squamous cell carcinomas of the vagina.

Authors:  Immaculada Alonso; Ana Felix; Aureli Torné; Victoria Fusté; Marta del Pino; Paola Castillo; Juan Balasch; Jaume Pahisa; Jose Rios; Jaume Ordi
Journal:  Gynecol Oncol       Date:  2012-01-04       Impact factor: 5.482

Review 9.  Primary small cell neuroendocrine carcinoma of the vagina: a clinicopathologic study.

Authors:  Zhanyong Bing; Lyuba Levine; Joseph A Lucci; Sandra S Hatch; Mahmoud A Eltorky
Journal:  Arch Pathol Lab Med       Date:  2004-08       Impact factor: 5.534

10.  Radiotherapy for carcinoma of the vagina. Immunocytochemical and cytofluorometric analysis of prognostic factors.

Authors:  P Blecharz; M Reinfuss; J Ryś; J Jakubowicz; P Skotnicki; W Wysocki
Journal:  Strahlenther Onkol       Date:  2013-04-05       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.